De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Doximity Dividend
Dividend criteriumcontroles 0/6
Doximity heeft geen dividenduitkeringen gedaan.
Belangrijke informatie
n/a
Dividendrendement
n/a
Uitbetalingsratio
| Gemiddelde opbrengst industrie | 0.9% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | n/a |
| Winst per aandeel | US$0.86 |
| Dividendrendementsvoorspelling | 0% |
Recente dividendupdates
Geen updates
Recent updates
Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors
Sep 23
There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump
Aug 18Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns
Aug 10Doximity Faces Slower Revenue Growth As R&D Costs May Rise
Jul 23Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?
Jul 23At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?
Jul 01Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking
Jun 09Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)
May 17Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal
May 04Doximity: Significant Upside Remains, But Not Until The Growth Story Returns
Apr 29With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For
Apr 16Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Mar 26Doximity: Rating Upgrade To Buy As Outlook Turns Positive
Feb 21We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit
Feb 15What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?
Feb 13Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan
Jan 16Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital
Jan 04Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price
Dec 14Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism
Nov 10Doximity: Adding Value Using AI But Faces Near-Term Risks
Nov 01Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?
Oct 30Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively
Sep 25Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook
Aug 24Doximity Earnings: Too Many Problems, Sell
Aug 09A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)
Jul 29Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching
Jul 09Doximity: Continue To See Positive Upside From Current Stock Level
Jul 05The Returns At Doximity (NYSE:DOCS) Aren't Growing
Jun 21Doximity: Digital Health Play With Strong Fundamentals
Jun 21A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Apr 07Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return
Mar 20Doximity: Good Business But Extremely Overvalued
Feb 18Doximity Q3 Earnings: Disappointing Results
Feb 10Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Dec 25Doximity: On The Right Path To Further Consolidate Market Share
Dec 22Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital
Dec 04Doximity up 16% after fiscal 2023 Q2 beats, FY revenue range includes consensus
Nov 10Doximity, down 9%, falls below IPO price
Oct 12Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Er zijn onvoldoende gegevens om te bepalen of het dividend per aandeel van DOCS in het verleden stabiel is geweest.
Groeiend dividend: Er zijn onvoldoende gegevens om te bepalen of de dividendbetalingen van DOCS zijn gestegen.
Dividendrendement versus markt
| Doximity Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (DOCS) | n/a |
| Markt onderkant 25% (US) | 1.4% |
| Markt Top 25% (US) | 4.3% |
| Gemiddelde industrie (Healthcare Services) | 0.9% |
| Analist prognose (DOCS) (tot 3 jaar) | 0% |
Opmerkelijk dividend: Het dividendrendement van DOCS kan niet worden vergeleken met dat van de onderste 25% van de dividendbetalers, aangezien het bedrijf geen recente uitbetalingen heeft gerapporteerd.
Hoog dividend: Het dividendrendement van DOCS kan niet worden vergeleken met dat van de top 25% van de dividendbetalers, aangezien het bedrijf geen recente uitbetalingen heeft gerapporteerd.
Winstuitkering aan aandeelhouders
Verdiendekking: Er zijn onvoldoende gegevens om de payout ratio DOCS te berekenen en vast te stellen of de dividendbetalingen worden gedekt door de winst.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: De duurzaamheid van het dividend kan niet worden berekend, omdat DOCS geen uitbetalingen heeft gerapporteerd.